Outcomes and Attributes Patients Value When Choosing Glucose-Lowering Medications: A Mixed-Methods Study.
Elizabeth H GolembiewskiAndrea E Garcia BautistaEric PolleyGuillermo E UmpierrezRodolfo J GalindoJuan P BritoVictor M MontoriJanet P GockermanMichael TesulovBertina LabatteMindy M MickelsonRozalina Grubina McCoyPublished in: Clinical diabetes : a publication of the American Diabetes Association (2024)
This mixed-methods study sought to identify pharmacotherapy preferences among 40 noninsulin-treated adults with type 2 diabetes receiving care at two U.S. health care systems. Participants ranked by relative importance various health outcomes and medication attributes and then contextualized their rankings. Most participants ranked blindness (63%), death (60%), heart attack (48%), and heart failure (48%) as the most important health outcomes and glucose-lowering efficacy (68%) as the most important medication attribute, followed by oral administration (45%) and lack of gastrointestinal side effects (38%).
Keyphrases
- healthcare
- heart failure
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- blood glucose
- palliative care
- atrial fibrillation
- randomized controlled trial
- type diabetes
- clinical trial
- quality improvement
- left ventricular
- metabolic syndrome
- blood pressure
- emergency department
- affordable care act
- pain management
- chronic pain
- decision making
- electronic health record
- weight loss
- health information
- drug induced
- glycemic control
- patient reported